Enphys Acquisition (US:NFYS)2023-11-20 21:44Financial Performance - For the three months ended September 30, 2023, the company reported a net income of $3,929,184, driven by interest income of $4,707,416 from investments in the Trust Account[112]. - For the nine months ended September 30, 2023, the company achieved a net income of $12,515,642, with total income from investments in the Trust Account amounting to $12,613,916[114]. - The company has not engaged in any operations or generated revenues to date, relying solely on interest income from marketable securities[111]. Liquidity and Capital Structure - As of September 30, 2023, the company had cash of $43,178 and a working capital deficit of $399,316, indicating potential liquidity challenges[116]. - A total of 24,301,795 shares of Class A Common Stock were redeemed at approximately $10.53 per share, resulting in an aggregate redemption amount of about $256 million[135]. - Following the redemption, the balance in the Trust Account was approximately $107 million[135]. - As of October 23, 2023, there were 17,010,705 shares of Class A Common Stock and 1,812,500 shares of Class B Common Stock outstanding[136]. Business Combination and Financing - The company has extended the deadline for completing a business combination from October 8, 2023, to February 8, 2024, as approved by shareholders[128]. - On October 30, 2023, the company issued a promissory note allowing it to borrow up to $300,000 from the Sponsor for operational costs related to a potential business combination[133]. Going Concern - Management has expressed substantial doubt about the company's ability to continue as a going concern for one year from the filing date[117].